NYSE · Healthcare Plans · USD
CVS Health Corporation (CVS) Stock Analysis
CVS Health Corporation (CVS) is a Healthcare Plans stock listed on NYSE and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
CVS Key Statistics
As of Oct 21, 2026Trading
- Open
- $95.26
- Previous Close
- $94.75
- Day's Range
- 93.43–95.26
- 52-Week Range
- 69.51–110.68
- Volume
- 6.52M
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.60
Valuation
- Market Cap
- $119.52B
- P/E Ratio
- 24.59
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 10.95
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 0.22
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 0.29
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 3.80
Financials (FY)
- Revenue (FY)
- $402.07B+7.85%
- Net Income (FY)
- $1.77B−61.68%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 1.18%
- Shares Outstanding
- 1.28B
- 1-Year Return
- +16.11%
Dividend and dates
- Dividend
- $2.66+2.81%
- Ex-Dividend Date
- October 22, 2026
- Earnings Date
- November 4, 2026
- Avg Volume
- 8.06M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, CVS closed at $93.45, +16.11% over 1 year.
CVS Health Corporation (CVS) has a market capitalization of $119.52B.
In fiscal 2025, CVS reported revenue of $402.07B.
CVS Stock Return by Calendar Year
CVS Health Corporation (CVS) 10-year return: what $10,000 became
- 1 year
- $10,000 $11,611
- +16.11%
- 5 years
- $10,000 $12,626
- +26.26%
- 10 years
- $10,000 $14,485
- +44.85%
If you had invested $10,000 in CVS Health Corporation (CVS) 10 years ago, at the close on October 21, 2016, it would have been worth $14,485 at the close on October 21, 2026: +44.85% in total, +3.78% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +20.51% |
| 2025 | +84.35% |
| 2024 | −40.77% |
| 2023 | −12.53% |
| 2022 | −7.63% |
| 2021 | +54.87% |
| 2020 | −5.14% |
| 2019 | +17.26% |
| 2018 | −7.04% |
| 2017 | −5.75% |
| 2016 (partial year) | −18.40% |
As of October 21, 2026.
CVS Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $402.07B | $1.77B | 0.4% |
| 2024 | $372.81B | $4.61B | 1.2% |
| 2023 | $357.78B | $8.34B | 2.3% |
| 2022 | $322.47B | $4.31B | 1.3% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $402.07B | $55.36B | $10.39B | $1.77B | 0.4% |
| 2024 | $372.81B | $51.40B | $9.70B | $4.61B | 1.2% |
| 2023 | $357.78B | $54.43B | $14.60B | $8.34B | 2.3% |
| 2022 | $322.47B | $54.50B | $16.29B | $4.31B | 1.3% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
CVS Dividend History
Dividends per share, 2025 · 4 payments
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026* | $2.00 | 3 | — |
| 2025 | $2.66 | 4 | +0.0% |
| 2024 | $2.66 | 4 | +9.9% |
| 2023 | $2.42 | 4 | +10.0% |
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026 (partial year) | $2.00 | 3 | — |
| 2025 | $2.66 | 4 | +0.0% |
| 2024 | $2.66 | 4 | +9.9% |
| 2023 | $2.42 | 4 | +10.0% |
| 2022 | $2.20 | 4 | +10.0% |
| 2021 | $2.00 | 4 | +0.0% |
| 2020 | $2.00 | 4 | +0.0% |
| 2019 | $2.00 | 4 | +0.0% |
| 2018 | $2.00 | 4 | +0.0% |
| 2017 | $2.00 | 4 | — |
Most recent payment: $0.67 per share, ex-dividend July 23, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.
CVS Valuation vs Healthcare Plans Median
Median of 11 stocks| Metric | CVS | Healthcare Plans median | vs median |
|---|---|---|---|
| P/E | 24.59 | 26.38 | 7% below |
| P/S ratio | 0.29 | 0.38 | 24% below |
| Profit margin | 1.18% | 1.18% | 0.0 pts above |
Medians across 11 Healthcare Plans stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
How Small Pharmacy Expansion Will Impact CVS Health (CVS) Investors
YahooCVS Health (CVS) Opens New Pharmacy Focused Locations
YahooCVS targets former Walgreens, Rite Aid customers after 1,000 stores close
TheStreetAlaska Airlines taps CVS Health exec for newly created tech role
Cio DiveHow CVS' Aetna Is Advancing Efforts to Reduce Administrative Burden
YahooCVS Health Collaborates With the Midlife Collective To Redefine a Woman’s Midlife Health Journey
Yahoo
All 20 articles ↓Show fewer ↑
Better Dividend Stock for Retirees: Bristol Myers Squibb vs. CVS Health
TIKRManagement Raised The Bar For CVS Health Stock; Does The Chart Agree?
TrefisCVS Caremark: Why Transparency Matters in Pharmacy Benefits
YahooCVS Caremark Is Transforming the Health Care Experience
YahooCVS settlement claim deadline is a month away. How to get money
USA TodayCVS Health (CVS) Exceeds Market Returns: Some Facts to Consider
YahooCVS Health collaborates with The Midlife Collective to redefine a woman's midlife health journey
YahooCVS Health - Early Detection Matters: Finding Heart Health Risks Earlier
YahooWhat Does CVS Health (CVS) Resolve With Its $315 Million Opioid Settlement?
YahooCVS to pay $315M to settle opioid prescribing allegations
Healthcare DiveCVS Settles DOJ Opioid Case for $315 Million: Here’s What It Means for the Stock
TIKRCVS Pharmacy(R) Celebrates Opening of First Pharmacy-Focused Location in Boston Area
YahooCVS Agrees to $315 Million Settlement Over Alleged Illegal Opioid Prescriptions
BenzingaCVS Agrees to $315M Settlement in Department of Justice Opioid Lawsuit Without Admitting Fault
firstformoney.com
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Healthcare Plans Stocks
UnitedHealth Group Incorporated
$374.30B
ELVElevance Health, Inc.
$94.15B
CIThe Cigna Group
$79.88B
HUMHumana Inc.
$51.08B
CNCCentene Corporation
$34.16B
MOHMolina Healthcare, Inc.
$11.22B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
MRKMerck & Co., Inc.
$369.78B
NVSNovartis AG
$292.58B













